Log In
BCIQ
Print this Print this
 

OX-CLI

  Manage Alerts
Collapse Summary General Information
Company Orexo AB
DescriptionLeukotriene C4 synthase (LTC4S) inhibitor
Molecular Target Leukotriene C4 synthase (LTC4S)
Mechanism of ActionLeukotriene C4 synthase (LTC4S) inhibitor
Therapeutic Modality 

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

2

0

$10.0M

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

01/25/2013

Undisclosed

Undisclosed

Undisclosed

06/07/2010

Undisclosed

$10.0M

Undisclosed

Get a free BioCentury trial today